Beijing Tongrentang Co., Ltd (SHA:600085)
36.72
+0.22 (0.60%)
May 13, 2025, 3:00 PM CST
Beijing Tongrentang Revenue
Beijing Tongrentang had revenue of 5.28B CNY in the quarter ending March 31, 2025, with 0.16% growth. This brings the company's revenue in the last twelve months to 18.61B, up 3.45% year-over-year. In the year 2024, Beijing Tongrentang had annual revenue of 18.60B with 4.12% growth.
Revenue (ttm)
18.61B
Revenue Growth
+3.45%
P/S Ratio
2.71
Revenue / Employee
1.04M
Employees
17,883
Market Cap
50.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
Dec 31, 2020 | 12.83B | -451.24M | -3.40% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |